Medical Robotics Stocks

The system is placed, the instruments are the business

Surgical robotics has a business model that explains its economics better than its technology does. The robot itself is expensive and sold or placed into a hospital, but the recurring revenue comes from the instruments consumed in every procedure and the service contract that keeps the system running. Over the life of an installed system, consumables and service typically exceed the value of the hardware. That is why the number of systems installed and the number of procedures performed on them are the two figures that matter.

The model creates powerful incumbency. A hospital that has bought a system, trained its surgeons on it and built its workflows around it is unlikely to switch, because the switching cost is measured in surgical training rather than in equipment. Competitors must therefore win new placements rather than displace existing ones.

The applications divide by specialty. Soft tissue surgery covers general, urological and gynaecological procedures and represents the largest installed base. Orthopaedic robotics assists joint replacement, where the value is in precision of bone preparation and implant positioning, and where the robot is often sold by a company that also sells the implant. Specialty systems address single procedures and compete by being better at one thing rather than adaptable to many.

The argument for the technology is measured in outcomes: less invasive access, shorter hospital stays, fewer complications. Whether those benefits justify the cost is decided by hospital economics and by what payers reimburse, which means adoption depends on health system budgets as much as on clinical evidence.

The companies in this group range from pure play robotics developers to large diversified device manufacturers for whom robotics is one line inside a much broader business, and the two respond very differently to the same news.

Stocks are sorted by today's price change, strongest first. Click any column header to sort by another measure, or switch to Charts for a daily candlestick of every name. This is not a recommendation to buy or sell any security. All information is provided for educational purposes only, and past performance does not guarantee future results.